Avoid common mistakes on your manuscript.
Retraction Note: Nanoscale Research Letters (2020) 15:196 https://doi.org/10.1186/s11671-020-03416-8
The Editors in Chief have retracted this article. After publication, concerns were raised about the following issues:
Apparent partial overlaps within both images in Fig. 1B.
Panel si-TGFBR3 in Fig. 3E appears to be similar to Fig. 4C, panel ADR (NC) in a previously published article by different authors [1, now retracted].
Panel miR-18a inhibitors in Fig. 3F seem similar to panel pcLINC00472 in Fig. 3B in a previously published paper by different authors [2] and panel CASC2 in Fig. 4c in a previously published paper by yet a different team of authors [3].
The authors did not respond to the request to clarify, as well to provide, raw data and the original ethics approval. The Editors in Chief, therefore, have lost confidence in the findings of this article. The authors did not respond to any correspondence from the Editors about this retraction.
References
RETRACTED ARTICLE: Xia W, Liu Y, Du Y, Cheng T, Hu X, Li X. MicroRNA-423 drug resistance and proliferation of breast cancer cells by targeting ZFP36. Onco Targets Ther. 2020; 13:769–782. https://doi.org/10.2147/OTT.S217745.
Zhang J, Zhang J, Zhang D, et al. Down-regulation of LINC00472 promotes osteosarcoma tumorigenesis by reducing FOXO1 expressions via miR-300. Cancer Cell Int. 2020;20:100. https://doi.org/10.1186/s12935-020-01170-6.
Wang C, Zhao J, Nan X, et al. Long noncoding RNA CASC2 inhibits ox-LDL-mediated vascular smooth muscle cells proliferation and migration via the regulation of miR-532-3p/PAPD5. Mol Med. 2020;26:74. https://doi.org/10.1186/s10020-020-00200-3.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Peng, Y., Li, X., Liu, H. et al. Retraction Note: microRNA-18a from M2 Macrophages Inhibits TGFBR3 to Promote Nasopharyngeal Carcinoma Progression and Tumor Growth via TGF-β Signaling Pathway. Discover Nano 18, 26 (2023). https://doi.org/10.1186/s11671-023-03811-x
Published:
DOI: https://doi.org/10.1186/s11671-023-03811-x